Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study

Andreas G. Wibmer; Michael J. Morris; Mithat Gonen; Junting Zheng; Hedvig Hricak; Steven Larson; Howard I. Scher; Hebert Alberto Vargas

doi:10.2967/jnumed.120.256602

Research ArticleClinical Investigation

Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with ¹⁸F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study

Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven Larson, Howard I. Scher and Hebert Alberto Vargas

Journal of Nuclear Medicine August 2021, 62 (8) 1050-1056; DOI: https://doi.org/10.2967/jnumed.120.256602

Andreas G. Wibmer

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Michael J. Morris

2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mithat Gonen

3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Junting Zheng

3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hedvig Hricak

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Steven Larson

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Howard I. Scher

2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Hebert Alberto Vargas

1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York;

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics
PDF

SNMMI members

SNMMI Member Login

Individuals

Non-Member Login

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 62, Issue 8

August 1, 2021

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with ¹⁸F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study